Original Article

Visualization of Myelin Basic Protein (MBP) T Cell Epitopes in Multiple Sclerosis Lesions using a Monoclonal Antibody Specific for the Human Histocompatibility Leukocyte Antigen (HLA)-DR2–MBP 85–99 Complex

Correspondence to: Lars Fugger, Dept. of Clinical Immunology, Aarhus University Hospital, Skejby Sygehus, DK-8200 N, Aarhus, Denmark. Tel:45-8949-5300 Fax:45-8949-5333 E-mail:fugger{at}inet.uni2.dk.

Susceptibility to multiple sclerosis (MS) is associated with the human histocompatibility leukocyte antigen (HLA)-DR2 haplotype, suggesting that major histocompatibility complex class II–restricted presentation of central nervous system–derived antigens is important in the disease process. Antibodies specific for defined HLA-DR2–peptide complexes may therefore be valuable tools for studying antigen presentation in MS. We have used phage display technology to select HLA-DR2–peptide-specific antibodies from HLA-DR2–transgenic mice immunized with HLA-DR2 molecules complexed with an immunodominant myelin basic protein (MBP) peptide (residues 85–99). Detailed characterization of one clone (MK16) demonstrated that both DR2 and the MBP peptide were required for recognition. Furthermore, MK16 labeled intra- and extracellular HLA-DR2–MBP peptide complexes when antigen-presenting cells (APCs) were pulsed with recombinant MBP. In addition, MK16 inhibited interleukin 2 secretion by two transfectants that expressed human MBP–specific T cell receptors. Analysis of the structural requirement for MK16 binding demonstrated that the two major HLA-DR2 anchor residues of MBP 85–99 and the COOH-terminal part of the peptide, in particular residues Val-96, Pro-98, and Arg-99, were important for binding. Based on these results, the antibody was used to determine if the HLA-DR2–MBP peptide complex is presented in MS lesions. The antibody stained APCs in MS lesions, in particular microglia/macrophages but also in some cases hypertrophic astrocytes. Staining of APCs was only observed in MS cases with the HLA-DR2 haplotype but not in cases that carried other haplotypes. These results demonstrate that HLA-DR2 molecules in MS lesions present a myelin-derived self-peptide and suggest that microglia/macrophages rather than astrocytes are the predominant APCs in these lesions.

Key Words: multiple sclerosis, antigen presentation, myelin basic protein, autoimmunity, microglia

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Klechevsky, E., Gallegos, M., Denkberg, G., Palucka, K., Banchereau, J., Cohen, C., Reiter, Y. (2008). Antitumor Activity of Immunotoxins with T-Cell Receptor-like Specificity against Human Melanoma Xenografts. Cancer Res. 68: 6360-6367 [Abstract] [Full Text]  
• Olazabal, I. M., Martin-Cofreces, N. B., Mittelbrunn, M., Martinez del Hoyo, G., Alarcon, B., Sanchez-Madrid, F. (2008). Activation Outcomes Induced in Naive CD8 T-Cells by Macrophages Primed via "Phagocytic" and Nonphagocytic Pathways. Mol. Biol. Cell 19: 701-710 [Abstract] [Full Text]  
• Nicholson, M. J., Moradi, B., Seth, N. P., Xing, X., Cuny, G. D., Stein, R. L., Wucherpfennig, K. W. (2006). Small Molecules That Enhance the Catalytic Efficiency of HLA-DM. J. Immunol. 176: 4208-4220 [Abstract] [Full Text]  
• Traherne, J. A., Barcellos, L. F., Sawcer, S. J., Compston, A., Ramsay, P. P., Hauser, S. L., Oksenberg, J. R., Trowsdale, J. (2006). Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum Mol Genet 15: 155-161 [Abstract] [Full Text]  
• Friese, M. A., Fugger, L. (2005). Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?. Brain 128: 1747-1763 [Abstract] [Full Text]  
• Stern, J. N. H., Illes, Z., Reddy, J., Keskin, D. B., Fridkis-Hareli, M., Kuchroo, V. K., Strominger, J. L. (2005). Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 102: 1620-1625 [Abstract] [Full Text]  
• Singh, R. A. K., Zhang, J. Z. (2004). Differential Activation of ERK, p38, and JNK Required for Th1 and Th2 Deviation in Myelin-Reactive T Cells Induced by Altered Peptide Ligand. J. Immunol. 173: 7299-7307 [Abstract] [Full Text]  
• Illes, Z., Stern, J. N. H., Reddy, J., Waldner, H., Mycko, M. P., Brosnan, C. F., Ellmerich, S., Altmann, D. M., Santambrogio, L., Strominger, J. L., Kuchroo, V. K. (2004). Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells. Proc. Natl. Acad. Sci. USA 101: 11749-11754 [Abstract] [Full Text]  
• Sun, W., Popat, U., Hutton, G., Zang, Y. C. Q., Krance, R., Carrum, G., Land, G. A., Heslop, H., Brenner, M., Zhang, J. Z. (2004). Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain 127: 996-1008 [Abstract] [Full Text]  
• Lutton, J. D., Winston, R., Rodman, T. C. (2004). Multiple Sclerosis: Etiological Mechanisms and Future Directions. Exp. Biol. Med. 229: 12-20 [Abstract] [Full Text]  
• Biddison, W. E., Turner, R. V., Gagnon, S. J., Lev, A., Cohen, C. J., Reiter, Y. (2003). Tax and M1 Peptide/HLA-A2-Specific Fabs and T Cell Receptors Recognize Nonidentical Structural Features on Peptide/HLA-A2 Complexes. J. Immunol. 171: 3064-3074 [Abstract] [Full Text]  
• Denkberg, G., Lev, A., Eisenbach, L., Benhar, I., Reiter, Y. (2003). Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen. J. Immunol. 171: 2197-2207 [Abstract] [Full Text]  
• Cohen, C. J., Sarig, O., Yamano, Y., Tomaru, U., Jacobson, S., Reiter, Y. (2003). Direct Phenotypic Analysis of Human MHC Class I Antigen Presentation: Visualization, Quantitation, and In Situ Detection of Human Viral Epitopes Using Peptide-Specific, MHC-Restricted Human Recombinant Antibodies. J. Immunol. 170: 4349-4361 [Abstract] [Full Text]  
• Karlsson, J., Zhao, X., Lonskaya, I., Neptin, M., Holmdahl, R., Andersson, A. (2003). Novel Quantitative Trait Loci Controlling Development of Experimental Autoimmune Encephalomyelitis and Proportion of Lymphocyte Subpopulations. J. Immunol. 170: 1019-1026 [Abstract] [Full Text]  
• Stuve, O., Youssef, S., Slavin, A. J., King, C. L., Patarroyo, J. C., Hirschberg, D. L., Brickey, W. J., Soos, J. M., Piskurich, J. F., Chapman, H. A., Zamvil, S. S. (2002). The Role of the MHC Class II Transactivator in Class II Expression and Antigen Presentation by Astrocytes and in Susceptibility to Central Nervous System Autoimmune Disease. J. Immunol. 169: 6720-6732 [Abstract] [Full Text]  
• Scheinecker, C., McHugh, R., Shevach, E. M., Germain, R. N. (2002). Constitutive Presentation of a Natural Tissue Autoantigen Exclusively by Dendritic Cells in the Draining Lymph Node. J. Exp. Med. 196: 1079-1090 [Abstract] [Full Text]  
• Cohen, C. J., Hoffmann, N., Farago, M., Hoogenboom, H. R., Eisenbach, L., Reiter, Y. (2002). Direct Detection and Quantitation of a Distinct T-Cell Epitope Derived from Tumor-specific Epithelial Cell-associated Mucin Using Human Recombinant Antibodies Endowed with the Antigen-specific, Major Histocompatibility Complex-restricted Specificity of T Cells. Cancer Res. 62: 5835-5844 [Abstract] [Full Text]  
• Chames, P., Willemsen, R. A., Rojas, G., Dieckmann, D., Rem, L., Schuler, G., Bolhuis, R. L., Hoogenboom, H. R. (2002). TCR-Like Human Antibodies Expressed on Human CTLs Mediate Antibody Affinity-Dependent Cytolytic Activity. J. Immunol. 169: 1110-1118 [Abstract] [Full Text]  
• Denkberg, G., Cohen, C. J., Lev, A., Chames, P., Hoogenboom, H. R., Reiter, Y. (2002). Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity. Proc. Natl. Acad. Sci. USA 99: 9421-9426 [Abstract] [Full Text]  
• Lev, A., Denkberg, G., Cohen, C. J., Tzukerman, M., Skorecki, K. L., Chames, P., Hoogenboom, H. R., Reiter, Y. (2002). Isolation and Characterization of Human Recombinant Antibodies Endowed with the Antigen-specific, Major Histocompatibility Complex-restricted Specificity of T Cells Directed toward the Widely Expressed Tumor T-cell Epitopes of the Telomerase Catalytic Subunit. Cancer Res. 62: 3184-3194 [Abstract] [Full Text]  
• Tompkins, S. M., Padilla, J., Dal Canto, M. C., Ting, J. P.-Y., Van Kaer, L., Miller, S. D. (2002). De Novo Central Nervous System Processing of Myelin Antigen Is Required for the Initiation of Experimental Autoimmune Encephalomyelitis. J. Immunol. 168: 4173-4183 [Abstract] [Full Text]  
• Forsthuber, T. G., Shive, C. L., Wienhold, W., de Graaf, K., Spack, E. G., Sublett, R., Melms, A., Kort, J., Racke, M. K., Weissert, R. (2001). T Cell Epitopes of Human Myelin Oligodendrocyte Glycoprotein Identified in HLA-DR4 (DRB1*0401) Transgenic Mice Are Encephalitogenic and Are Presented by Human B Cells. J. Immunol. 167: 7119-7125 [Abstract] [Full Text]  
• Neuhaus, O., Farina, C., Wekerle, H., Hohlfeld, R. (2001). Mechanisms of action of glatiramer acetate in multiple sclerosis. Neurology 56: 702-708 [Abstract] [Full Text]  
• Neuhaus, O., Farina, C., Yassouridis, A., Wiendl, H., Then Bergh, F., Dose, T., Wekerle, H., Hohlfeld, R. (2000). Multiple sclerosis: Comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc. Natl. Acad. Sci. USA 97: 7452-7457 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS